BillionToOne Plans to Release Q3 2025 Financial Results
BillionToOne, Inc. (NASDAQ: BLLN), a leader in molecular diagnostics, is preparing to unveil its financial results for the third quarter of 2025. The announcement is scheduled to take place after the market closes on December 9, 2025.
Conference Call Scheduled for Financial Discussion
A conference call is set for the same day at 1:30 PM Pacific Time / 4:30 PM Eastern Time, where the management team will discuss the company's performance and answer any questions from analysts and investors.
How to Participate in the Conference Call
To join the call, participants are encouraged to register in advance. A live and archived webcast will also be available on BillionToOne's investor relations website, ensuring that the information is accessible to all interested parties.
About BillionToOne
BillionToOne is based in Menlo Park, California, and has established itself as a crucial player in the field of molecular diagnostics. The company’s innovative approach focuses on creating precise tests aimed at making advanced diagnostics accessible to everyone. Its standout technology, the Quantitative Counting Templates™ (QCT™), enables accurate counting of DNA molecules, representing a significant advancement in the realm of molecular diagnostics.
Investor Contact Information
Those interested in more information or having inquiries can reach out to the company via email at ir@billiontoone.com.
Media Inquiries
For media inquiries, please contact BillionToOne at billiontoone@moxiegrouppr.com for assistance.
Frequently Asked Questions
What is the date for BillionToOne’s Q3 2025 earnings release?
The earnings release is scheduled for December 9, 2025.
What time will the conference call take place?
The conference call is set for 1:30 PM Pacific Time / 4:30 PM Eastern Time on the same day.
Where can I access the earnings call webcast?
The webcast will be available on BillionToOne's investor relations website.
What technology does BillionToOne utilize?
The company uses the Quantitative Counting Templates™ (QCT™) platform for precise DNA molecule counting.
How can investors contact BillionToOne for more information?
Investors can reach out through ir@billiontoone.com.